|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heist RS and Engelman JA: SnapShot:
Non-small cell lung cancer. Cancer Cell. 21:e448–e442. 2012.
View Article : Google Scholar
|
|
3
|
Auperin A, Le Pechoux C, Rolland E, Curran
WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus
R, et al: Meta-analysis of concomitant versus sequential
radiochemotherapy in locally advanced non-small-cell lung cancer. J
Clin Oncol. 28:2181–2190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y and Srivastava D: A developmental
view of microRNA function. Trends Biochem Sci. 32:189–197. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hao J, Zhao S, Zhang Y, Zhao Z, Ye R, Wen
J and Li J: Emerging role of microRNAs in cancer and cancer stem
cells. J Cell Biochem. 115:605–610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Raponi M, Dossey L, Jatkoe T, Wu X, Chen
G, Fan H and Beer DG: MicroRNA classifiers for predicting prognosis
of squamous cell lung cancer. Cancer Res. 69:5776–5783. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mitomo S, Maesawa C, Ogasawara S, Iwaya T,
Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu
N, et al: Downregulation of miR-138 is associated with
overexpression of human telomerase reverse transcriptase protein in
human anaplastic thyroid carcinoma cell lines. Cancer Sci.
99:280–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ding J, Yeh CR, Sun Y, Lin C, Chou J, Ou
Z, Chang C, Qi J and Yeh S: Estrogen receptor β promotes renal cell
carcinoma progression via regulating LncRNA
HOTAIR-miR-138/200c/204/217 associated CeRNA network. Oncogene.
37:5037–5053. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peng J, Hou F, Feng J, Xu SX and Meng XY:
Long non-coding RNA BCYRN1 promotes the proliferation and
metastasis of cervical cancer via targeting microRNA-138 in
vitro and in vivo. Oncol Lett. 15:5809–5818.
2018.PubMed/NCBI
|
|
12
|
Gao Y, Fan X, Li W, Ping W, Deng Y and Fu
X: miR-138-5p reverses gefitinib resistance in non-small cell lung
cancer cells via negatively regulating G protein-coupled receptor
124. Biochem Biophys Res Commun. 446:179–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakamura A, Nakata D, Kakoi Y, Kunitomo M,
Murai S, Ebara S, Hata A and Hara T: CDK8/19 inhibition induces
premature G1/S transition and ATR-dependent cell death in prostate
cancer cells. Oncotarget. 9:13474–13487. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu C, Zhao Y, Zhang Z, Ni Y, Li X and
Yong H: MicroRNA-33a inhibits lung cancer cell proliferation and
invasion by regulating the expression of β-catenin. Mol Med Rep.
11:3647–3651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Z, Zhang Y, Sun XX, Ma X and Chen
ZN: microRNA-146a inhibits cancer metastasis by downregulating VEGF
through dual pathways in hepatocellular carcinoma. Mol Cancer.
14:52015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu G, Fu D, Jia C, Chai L, Han Y, Liu J,
Wu T, Xie R, Chang Z, Yang H, et al: Reduced miR-105-1 levels are
associated with poor survival of patients with non-small cell lung
cancer. Oncol Lett. 14:7842–7848. 2017.PubMed/NCBI
|
|
22
|
Li Y, Zhang H, Dong Y, Fan Y, Li Y, Zhao
C, Wang C, Liu J, Li X, Dong M, et al: MiR-146b-5p functions as a
suppressor miRNA and prognosis predictor in non-small cell lung
cancer. J Cancer. 8:1704–1716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang R, Liu M, Liang H, Guo S, Guo X, Yuan
M, Lian H, Yan X, Zhang S, Chen X, et al: miR-138-5p contributes to
cell proliferation and invasion by targeting Survivin in bladder
cancer cells. Mol Cancer. 15:822016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z,
Liu R, Tang A, Li X, Liu F and Shen S: The tumor suppressor
miR-138-5p targets PD-L1 in colorectal cancer. Oncotarget.
7:45370–45384. 2016.PubMed/NCBI
|
|
25
|
Serrao A, Jenkins LM, Chumanevich AA,
Horst B, Liang J, Gatza ML, Lee NY, Roninson IB, Broude EV and
Mythreye K: Mediator kinase CDK8/CDK19 drives YAP1-dependent
BMP4-induced EMT in cancer. Oncogene. 37:4792–4808. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Philip S, Kumarasiri M, Teo T, Yu M and
Wang S: Cyclin-dependent kinase 8: A new hope in targeted cancer
therapy? J Med Chem. 61:5073–5092. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luo Q, Zhang Z, Dai Z, Basnet S, Li S, Xu
B and Ge H: Tumor-suppressive microRNA-195-5p regulates cell growth
and inhibits cell cycle by targeting cyclin dependent kinase 8 in
colon cancer. Am J Transl Res. 8:2088–2096. 2016.PubMed/NCBI
|
|
28
|
Li M, Tian L, Ren H, Chen X, Wang Y, Ge J,
Wu S, Sun Y, Liu M and Xiao H: MicroRNA-101 is a potential
prognostic indicator of laryngeal squamous cell carcinoma and
modulates CDK8. J Transl Med. 13:2712015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Zhang L, Yin ZY, Fan XL, Hu B,
Wang LQ and Zhang D: miR-107 regulates cisplatin chemosensitivity
of A549 non small cell lung cancer cell line by targeting cyclin
dependent kinase 8. Int J Clin Exp Pathol. 7:7236–7241.
2014.PubMed/NCBI
|
|
30
|
Liu ZJ, Ueda T, Miyazaki T, Tanaka N, Mine
S, Tanaka Y, Taniguchi T, Yamamura H and Minami Y: A critical role
for cyclin C in promotion of the hematopoietic cell cycle by
cooperation with c-Myc. Mol Cell Biol. 18:3445–3454. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He SB, Yuan Y, Wang L, Yu MJ, Zhu YB and
Zhu XG: Effects of cyclin-dependent kinase 8 specific siRNA on the
proliferation and apoptosis of colon cancer cells. J Exp Clin
Cancer Res. 30:1092011. View Article : Google Scholar : PubMed/NCBI
|
